BURROUGHS WELLCOME’s MEPRON (ATOVAQUONE) IS A SECOND-LINE THERAPY FOR MILD TO MODERATE PCP IN PATIENTS "INTOLERANT" TO TMP/SMX, ADVISORY CMTE. CONCURS

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".